Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122713) titled 'Dose-response relationship of tegileridine in inhibiting propofol-induced responses to laryngeal mask airway insertion: A sequential trial' on April 16.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Lanzhou University Second Hospital

Condition: None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-16

Target Sample Size: Experimental group:0;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312933

Published by HT Digital Content Services with permission from Health Daily Digest....